Position in TNYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$185,804
+$37,403 QoQ
Shares Held
268,505
+28.8% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 103 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 26.431537587754416.ToString("F0")%
Shared 0.ToString("F0")%
None 73.56846241224558.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. TNYA ranks #331 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in TNYA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $185,804 | 268,505 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $148,401 | 208,431 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $270,683 | 167,089 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $70,800 | 115,879 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $179,290 | 314,549 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,128,275 | 1,488,306 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $604,071 | 312,991 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $550,938 | 177,723 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,652,096 | 315,889 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $751,697 | 232,006 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $214,255 | 84,023 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $659,592 | 112,367 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $229,190 | 80,419 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $55,995 | 27,860 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $41,347 | 14,259 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $73,757 | 13,101 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $135,904 | 11,537 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $572,251 | 30,198 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $63,312 | 3,066 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||